Growth factors and their downstream signaling pathways play vital roles in many processes, from development to homeostasis, and are targeted in many cancer cell types. However, how these growth factor pathways are regulated at or before the level of the receptors on the target cell has remained largely elusive. We have used the C. elegans TGF superfamily pathway that regulates body size and male tail formation (Sma/Mab) to improve our understanding of the regulation of growth factor signaling and have focused on two interesting conserved genes. Mutations in core pathway genes, which encode the ligand
dbl-1, the receptors
sma-6 and
daf-4, and Smads
sma-2,
sma-3, and
sma-4, result in animals that are smaller than the wild type and have male tail ray fusions and crumpled spicules.
lon-2 was identified by Brenner as a gene involved in body length regulation, as mutations in it result in animals that are longer than the wild type.
lon-2 acts genetically upstream of
dbl-1. We show that LON-2 is a conserved glypican that regulates DBL-1 signaling, and is expressed in the intestine to regulate DBL-1's activity in the hypodermis. The Drosophila glypican dally can partially rescue the body size defect in animals without functional
lon-2. Glypicans have been shown to affect growth factor signaling, but the precise mechanism remains unclear. We propose that LON-2 is a negative regulator of DBL-1, acting as a reservoir for ligand and affecting DBL-1's interaction with or activation of its receptors. The Padgett lab also performed a screen for Sma animals and identified lesions in a gene we named
sma-10 (Savage-Dunn et al, Genesis (2003) 34(4): 239-247). It acts genetically in the unique position between
lon-2 and the ligand. We cloned this gene and found that it encodes a predicted extracellular protein with immunoglobulin domains and leucine rich repeats. There is one related protein in Drosophila and three in vertebrates, though there is little genetic information on these genes and nothing that yet links them to growth factor regulation. SMA-10:GFP localizes to the hypodermis where
sma-10 expression is required, and where the core
dbl-1 pathway acts. The Drosophila homolog rescues the
sma-10(lf) Sma phenotype. Interestingly, neither
lon-2 nor
sma-10 affects male tail morphogenesis, suggesting cell-type specificity in their regulation of
dbl-1. We propose that SMA-10 defines a new family of positive regulators that are required for TGF signaling.